Home/Pipeline/Third Autologous Cell Therapy Program

Third Autologous Cell Therapy Program

Incontinence Disorder

Clinical DevelopmentActive

Key Facts

Indication
Incontinence Disorder
Phase
Clinical Development
Status
Active
Company

About Innovacell Biotechnologie

A regenerative medicine company developing autologous cell therapies for fecal and urinary incontinence.

View full company profile

Therapeutic Areas